There’s a new pill for postpartum depression, but many at-risk women face hurdles

About 1 in 8 women suffer postpartum depression. With a new drug on the market approved by the U.S. Food and Drug Administration for the condition, experts and advocates are urging state Medicaid agencies and insurers to ensure equitable access to the treatment. (John Moore/Getty Images)The first pill for postpartum depression approved by the U.S. Food and Drug Administration is…